Results 121 to 130 of about 3,566 (133)

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

Clinical Pharmacokinetics, 2017
Michel M R F Struys, Laura N Hannivoort, Clemens R M Barends   +2 more
exaly  

The sympathetic control of blood pressure

Nature Reviews Neuroscience, 2006
Patrice G Guyenet
exaly  

Direct Vasodilators and Sympatholytic Agents

Journal of Cardiovascular Pharmacology and Therapeutics, 2016
Tien M H Ng
exaly  

Indirect Sympatholytic Actions at β-Adrenoceptors Account for the Ocular Hypotensive Actions of Cannabinoid Receptor Agonists

Journal of Pharmacology and Experimental Therapeutics, 2011
Brian D Hudson
exaly  

Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women

Journal of Hypertension, 2008
exaly  

Central Sympatholytic Drugs

Journal of Clinical Hypertension, 2011
Wanpen Vongpatanasin
exaly  

Mechanisms of the Anti-Infl ammatory and Antifi brotic Activity of a Sympatholytic Agent during Toxic Pulmonary Fibrosis

Bulletin of Experimental Biology and Medicine, 2012
Evgenii Skurikhin, Ekaterina Khmelevskaya, Olga Pershina   +2 more
exaly  

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

Diabetes Care, 2011
exaly  

Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers

British Journal of Anaesthesia, 2018
Shamgar Ben-Eliyahu
exaly  

An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation

BJU International, 2001
exaly